PD-L1 expression in ROS1-rearranged non-small cell lung cancer: A study using simultaneous genotypic screening of EGFR, ALK, and ROS1

Medicine and Dentistry

• Screening 100%
• Non Small Cell Lung Cancer 100%
• Epidermal Growth Factor Receptor 100%
• Neoplasm 18%
• Prevalence 9%
• Assay 9%
• Age 4%
• Therapeutic Procedure 4%
• Patient 4%
• Inpatient 4%
• Clinical Feature 4%
• Adenocarcinoma 4%
• Biological Marker 4%
• Diagnosis 4%
• Genotype 4%
• Woman 4%
• Fluorescence in Situ Hybridization 4%
• Aberration 4%
• Peptide Nucleic Acid 4%

Biochemistry, Genetics and Molecular Biology

• Screening 100%
• PD-L1 100%
• ROS1 100%
• Mutation 13%
• Prevalence 9%
• Time 4%
• Sample 4%
• Age 4%
• Fluorescence in Situ Hybridization 4%
• Genetics 4%
• Genotyping 4%
• Wild Type 4%
• Peptide Nucleic Acid 4%

Pharmacology, Toxicology and Pharmaceutical Science

• Non Small Cell Lung Cancer 100%
• Programmed Death-Ligand 1 100%
• Neoplasm 18%
• Prevalence 9%
• Clinical Feature 4%
• Adenocarcinoma 4%
• Biological Marker 4%